Concord Drugs Quarterly Results for Trading Insights
CONCORD • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QSept 2025
Concord Drugs Quarterly Results Key Highlights
- Revenue of ₹10 Cr in Sept 2025 (+0.0% vs Mar 2025, -16.7% vs Sept 2024)
- EBITDA of ₹1 Cr in Sept 2025 (+0.0% vs Mar 2025)
- Operating Margin of 11.0% in Sept 2025 (+1.0pp vs Mar 2025)
- Earnings Per Share of ₹0.19 in Sept 2025 (+375.0% vs Mar 2025)
Concord Drugs Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 10 | 10 | 14 | 12 | 16 | - | -16.7% |
| Net Profit (₹ Cr) | 0 | 0 | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 1 | 1 | 1 | 1 | 0 | - | - |
| EPS (₹) | 0.19 | 0.04 | 0.12 | 0.04 | -0.34 | - | - |
| Operating Margin (%) | 11.0% | 10.0% | 7.0% | 7.0% | 2.0% | - | - |
Concord Drugs Share Price Trend Around Quarterly Results
Visualize Concord Drugs's 1-year price movement across quarterly results — ideal for logging trades in Concord Drugs share price
chart using Tickjournal. All values in ₹.
Related Pages for Concord Drugs
Additional stock information and data for CONCORD
Revenue Trend (₹ Cr)
Sept 2024
12
Jun 2025
14
Mar 2025
10
Sept 2025
10
Net Profit Trend (₹ Cr)
Sept 2024
0
Jun 2025
0
Mar 2025
0
Sept 2025
0
Operating Margin Trend (%)
Sept 2024
7.0%
Jun 2025
7.0%
Mar 2025
10.0%
Sept 2025
11.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Concord Drugs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores